[
    [
        {
            "time": "2020-12-02",
            "original_text": "拜恩泰科新冠疫苗在英国获批准紧急使用，世卫组织正在审查数据",
            "features": {
                "keywords": [
                    "拜恩泰科",
                    "新冠疫苗",
                    "英国",
                    "紧急使用",
                    "世卫组织"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "拜恩泰科新冠疫苗在英国获批准紧急使用，世卫组织正在审查数据",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "复宏汉霖生物药汉曲优获得医保编码，中欧两地商业化继续推进",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "汉曲优",
                    "医保编码",
                    "中欧",
                    "商业化"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复宏汉霖生物药汉曲优获得医保编码，中欧两地商业化继续推进",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "辉瑞/BioNTech新冠疫苗获批，两大概念站上风口",
            "features": {
                "keywords": [
                    "辉瑞",
                    "BioNTech",
                    "新冠疫苗",
                    "获批",
                    "概念"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "辉瑞/BioNTech新冠疫苗获批，两大概念站上风口",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "全球首款mRNA新冠核酸疫苗下周英国开打，复星医药正积极推进中国临床研究",
            "features": {
                "keywords": [
                    "mRNA",
                    "新冠疫苗",
                    "英国",
                    "复星医药",
                    "临床研究"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "全球首款mRNA新冠核酸疫苗下周英国开打，复星医药正积极推进中国临床研究",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "普通民众下周接种！辉瑞新冠疫苗获英国紧急使用授权",
            "features": {
                "keywords": [
                    "普通民众",
                    "辉瑞",
                    "新冠疫苗",
                    "英国",
                    "紧急使用"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "普通民众下周接种！辉瑞新冠疫苗获英国紧急使用授权",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "兆信股份获得复星集团近亿元战略投资",
            "features": {
                "keywords": [
                    "兆信股份",
                    "复星集团",
                    "战略投资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "兆信股份获得复星集团近亿元战略投资",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "利尔化学今年净利预增80%以上，多股有望开启上涨行情",
            "features": {
                "keywords": [
                    "利尔化学",
                    "净利预增",
                    "上涨行情"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "利尔化学今年净利预增80%以上，多股有望开启上涨行情",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "肿瘤领域成资本市场关注的热点，药企融资不断",
            "features": {
                "keywords": [
                    "肿瘤领域",
                    "资本市场",
                    "药企融资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "肿瘤领域成资本市场关注的热点，药企融资不断",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "最新公告透露利好，12只个股有望爆发（12.02）",
            "features": {
                "keywords": [
                    "公告",
                    "利好",
                    "个股",
                    "爆发"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最新公告透露利好，12只个股有望爆发（12.02）",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-02",
            "original_text": "中泰证券：新冠疫苗数据持续积极，逐步进入兑现期，持续看好板块成长",
            "features": {
                "keywords": [
                    "中泰证券",
                    "新冠疫苗",
                    "数据积极",
                    "兑现期",
                    "板块成长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中泰证券：新冠疫苗数据持续积极，逐步进入兑现期，持续看好板块成长",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]